Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China flag China · Delayed Price · Currency is CNY
2.380
-0.070 (-2.86%)
At close: Feb 13, 2026

SHA:603077 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6,8216,9993,0644,5911,711845.86
Trading Asset Securities
----56.89-
Cash & Short-Term Investments
6,8216,9993,0644,5911,768845.86
Cash Growth
165.76%128.43%-33.26%159.70%109.01%6.19%
Accounts Receivable
1,7552,0432,0492,5681,6561,682
Other Receivables
52.2330.0734.3523.0919.5514.75
Receivables
1,8072,0732,0842,5911,6751,697
Inventory
4,0604,5454,4032,076912.2633.27
Other Current Assets
385.56385.99303.87460.25287.84141.95
Total Current Assets
13,07414,0039,8559,7194,6433,318
Property, Plant & Equipment
9,9049,9529,6849,4838,2957,513
Long-Term Investments
877.47857.45667.27677.37661.99645.59
Goodwill
1,8381,8381,8381,8381,9041,904
Other Intangible Assets
2,6672,3892,2002,1431,9671,018
Long-Term Deferred Tax Assets
135.42127.2350.38110.325.8385.94
Long-Term Deferred Charges
220.82174.48105.4634.017.299.85
Other Long-Term Assets
575.96308.09142.1697.84417.19245.29
Total Assets
29,29429,65024,54224,10317,92214,740
Accounts Payable
983.532,1081,8771,8771,1561,042
Accrued Expenses
45.3976.21103.0191.37126.2479.69
Short-Term Debt
2,5522,3531,1681,2221,1711,602
Current Portion of Long-Term Debt
434.59745.33342.3216495279
Current Portion of Leases
-5.972.442.44--
Current Income Taxes Payable
61.7814.8755.0195.71140.7921.78
Current Unearned Revenue
149.4245.196.6235.07371.54113.74
Other Current Liabilities
38.0426.1525.4346.562.0713.87
Total Current Liabilities
4,2655,3753,6703,7343,1233,152
Long-Term Debt
5,9324,936431.17408.4868.09262.4
Long-Term Leases
13.8914.5224.9421.5437.06-
Long-Term Unearned Revenue
127.36130.1775.2579.0316.7915.86
Long-Term Deferred Tax Liabilities
190.15187.92122.7596.0239.992.3
Total Liabilities
10,52810,6434,3244,3393,2853,433
Common Stock
8,8318,8318,8318,8318,8318,831
Additional Paid-In Capital
948.651,0351,1251,095470.46212.9
Retained Earnings
10,17610,07810,2049,3135,6422,619
Treasury Stock
-1,790-1,697-650.37-150-700-520.07
Comprehensive Income & Other
356.44379.1566.429.451.9-1.24
Total Common Equity
18,52318,62619,57519,11814,24511,142
Minority Interest
242.82380.13643.04644.86391.84165.66
Shareholders' Equity
18,76619,00720,21819,76314,63711,307
Total Liabilities & Equity
29,29429,65024,54224,10317,92214,740
Total Debt
8,9338,0551,9691,8181,3722,144
Net Cash (Debt)
-2,111-1,0561,0962,773396.4-1,298
Net Cash Growth
---60.49%599.57%--
Net Cash Per Share
-0.26-0.120.130.320.05-0.15
Filing Date Shares Outstanding
7,9748,0228,5128,7258,3948,518
Total Common Shares Outstanding
7,9748,0228,5128,7258,3948,518
Working Capital
8,8108,6296,1855,9851,520165.62
Book Value Per Share
2.322.322.302.191.701.31
Tangible Book Value
14,01714,39915,53715,13710,3748,219
Tangible Book Value Per Share
1.761.791.831.731.240.96
Buildings
-3,7663,5642,856-2,065
Machinery
-11,30311,67710,357-7,313
Construction In Progress
-2,3541,1741,885-2,320
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.